Clinical Trial

A Study of MHB039A for Advanced Solid Tumor

Active, Not Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
Phase I/II open label, multicenter study to evaluate the efficacy and safety of MHB039A in advanced malignant tumors.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-04-01.
Status change: Not Yet Recruiting → Active, Not Recruiting 2025-11-17
Trial Details
NCT Number NCT06345482
Lead Sponsor Minghui Pharmaceutical (Hangzhou) Ltd
Conditions Advanced Solid Tumor
Enrollment 196 participants
Start Date 2024-04-16
Primary Completion 2028-04-01 (estimated)
Study Completion 2029-06-01 (estimated)
Updated on ClinicalTrials.gov 2025-11-20